Session information

Morning Seminar

MS3-9 Prognostic Impact of WT1 mRNA in AML Patients: Overview and Future Perspectives

Sun. Oct 13, 2019 7:55 AM - 8:40 AM No.9 (Tokyo International Forum, 4F G402)

Chair: Koiti Inokuchi（Department of Hematology, Nippon Medical School）

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Akira Shimada (Department of Pediatric Hematology/Oncology, Okayama University Hospital)

Yasunori Ueda (Department of Hematology/Oncology, Kurashiki Central Hospital)